Gallbladder cancer (GBC) is a highly aggressive cancer with poor prognosis, making early diagnosis crucial for better treatment outcomes.
Current diagnostic methods mainly involve a combination of clinical, radiological, and pathological assessments, but there's a risk of missed or incorrect diagnoses.
The review also discusses the potential of advanced technologies like artificial intelligence and liquid biopsy to enhance GBC diagnosis, while stressing the need for multidisciplinary teamwork and further validation of these innovative approaches.